Our Mission: Save more lives by fueling the discovery and development of powerful immunotherapies for all types of cancer.
Working in tandem with our global network of researchers, supporters, patients, and advocates, we're funding the best scientists doing the most promising research—all while promoting awareness, sharing up-to-date immunotherapy information, and inspiring lifelong advocacy for the cause.
We support the science behind the treatment, funding lifesaving immunotherapy research and clinical trials around the world.
Meet Our Scientists
Your trusted resource for the latest credible, accurate cancer immunotherapy information for scientists, patients, and supporters.
Learn How Immunotherapy Works
Join us in the cause to cure all cancers, advancing immunotherapy through events and awareness campaigns.
Create a Fundraising Team
Connecting you to an inspiring network of patients and advocates—that's a crucial part of our mission. See real stories of immunotherapy experiences, or share your own with others looking for insight and information.
Meet Your ImmunoCommunity
We are the Cancer Research Institute, a 501(c)(3) nonprofit organization dedicated to harnessing our immune system's power to control and potentially cure all types of cancer. We fund the most innovative clinical and laboratory research around the world, support the next generation of the field's leaders, and serve as the trusted source of information on immunotherapy for cancer patients and their caregivers.
We're working for you—all of our supporters, patients, and scientists—to make the biggest impact possible in supporting cancer immunotherapy research to save more lives.
*Immunotherapy results may vary from patient to patient.
Cancer Research Institute | National Headquarters
29 Broadway, Floor 4 | New York, NY 10006-3111
In February 2017, Oswald became one of the first patients to receive pembrolizumab (Keytruda®) as first-line therapy for non-small cell lung cancer.
Dr. Kunle Odunsi discusses genomic testing, new treatments, and promising clinical trials in immunotherapy for ovarian cancer.